BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 2125610)

  • 1. Prolactin response to growth hormone-releasing hormone during chronic thyrotropin-releasing hormone infusion in the treatment of amyotrophic lateral sclerosis.
    Chiodini PG; Attanasio R; Liuzzi A; Cozzi R; Orlandi P; De Palo C; Dallabonzana D; Girotti F; Testa D
    J Endocrinol Invest; 1990 Sep; 13(8):631-6. PubMed ID: 2125610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained rises in serum thyrotropin, thyroxine, and triiodothyronine during long term, continuous thyrotropin-releasing hormone treatment in patients with amyotrophic lateral sclerosis.
    Kaplan MM; Taft JA; Reichlin S; Munsat TL
    J Clin Endocrinol Metab; 1986 Oct; 63(4):808-14. PubMed ID: 3091628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyotrophic lateral sclerosis: thyroid and prolactin hormone changes in thyrotropin-releasing hormone therapy.
    Testa D; Chiodini PG; Girotti F; Attanasio R
    Ital J Neurol Sci; 1990 Dec; 11(6):601-3. PubMed ID: 2127925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical, electrophysiologic and endocrine effects of the perfusion of high doses of TRH in amyotrophic lateral sclerosis].
    Gueguen B; Puymirat J; Grouselle D; Piketty ML; Bleton JP; Bourdel MC; Rondot P
    Rev Neurol (Paris); 1988; 144(11):704-9. PubMed ID: 3148186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tartrate thyrotropin-releasing hormone treatment on serum thyrotropin, free triiodothyronine, free thyroxine and prolactin levels in patients with spinocerebellar degeneration.
    Merola B; Colao A; Di Renzo G; Filla A; Campanella G; Lombardi G
    Horm Res; 1992; 38(3-4):160-3. PubMed ID: 1306848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.
    Van den Berghe G; de Zegher F; Bowers CY; Wouters P; Muller P; Soetens F; Vlasselaers D; Schetz M; Verwaest C; Lauwers P; Bouillon R
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):341-51. PubMed ID: 8949573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum thyrotropin and prolactin in the syndrome of generalized resistance to thyroid hormone: responses to thyrotropin-releasing hormone stimulation and short term triiodothyronine suppression.
    Sarne DH; Sobieszczyk S; Ain KB; Refetoff S
    J Clin Endocrinol Metab; 1990 May; 70(5):1305-11. PubMed ID: 2110573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of simultaneous administration of GHRH (1-40) and TRH on GH, PRL and TSH secretion in normal man.
    Giusti M; Lomeo A; Mazzocchi G; Torre R; Monachesi M; Sessarego P; Attanasio R; Giordano G
    J Endocrinol Invest; 1986 Dec; 9(6):497-501. PubMed ID: 3106459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma thyrotropin-releasing hormone, prolactin, thyrotropin, and thyroxine concentrations following the intravenous or oral administration of thyrotropin-releasing hormone.
    Andreassen B; Huth J; Tyson JE
    Am J Obstet Gynecol; 1979 Nov; 135(6):737-42. PubMed ID: 115316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone-releasing peptide-2 infusion synchronizes growth hormone, thyrotrophin and prolactin release in prolonged critical illness.
    Van den Berghe G; Wouters P; Bowers CY; de Zegher F; Bouillon R; Veldhuis JD
    Eur J Endocrinol; 1999 Jan; 140(1):17-22. PubMed ID: 10037246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone.
    Foley TP; Jacobs LS; Hoffman W; Daughaday WH; Blizzard RM
    J Clin Invest; 1972 Aug; 51(8):2143-50. PubMed ID: 4626583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different prolactin, thyrotropin, and thyroxine responses after prolonged intermittent or continuous infusions of thyrotropin-releasing hormone in rhesus monkeys.
    Pavasuthipaisit K; Norman RL; Ellinwood WE; Oyama TT; Baughman WL; Spies HG
    J Clin Endocrinol Metab; 1983 Mar; 56(3):541-8. PubMed ID: 6401761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyrotrophin and prolactin release in prolonged critical illness: dynamics of spontaneous secretion and effects of growth hormone-secretagogues.
    Van den Berghe G; de Zegher F; Veldhuis JD; Wouters P; Gouwy S; Stockman W; Weekers F; Schetz M; Lauwers P; Bouillon R; Bowers CY
    Clin Endocrinol (Oxf); 1997 Nov; 47(5):599-612. PubMed ID: 9425400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in basal and TRH-stimulated serum levels of thyrotropin, prolactin, and thyroid hormones in starved obese men.
    Carlson HE; Drenick EJ; Chopra IJ; Hershman JM
    J Clin Endocrinol Metab; 1977 Oct; 45(4):707-13. PubMed ID: 410822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of thyroliberin treatment on the thyrotropin and prolactin levels in patients with amyotrophic lateral sclerosis].
    Klimek A; Szulc-Kuberska J; Stepień H
    Neurol Neurochir Pol; 1990; 24(1-2):31-6. PubMed ID: 2132051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyrotropin and prolactin secretory patterns during 24-hours infusion of thyrotropin-releasing hormone in calves.
    Ohlson DL; Davis SL; Anfinson MS; Klindt J
    Neuroendocrinology; 1978; 26(3):163-73. PubMed ID: 98724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of long-term low dose thyrotropin-releasing hormone infusions on serum thyrotropin and prolactin concentrations in man.
    Spencer CA; Greenstadt MA; Wheeler WS; Kletzky OA; Nicoloff JT
    J Clin Endocrinol Metab; 1980 Oct; 51(4):771-5. PubMed ID: 6774994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral thyrotropin-releasing hormone (TRH) test in acromegaly.
    Marek J; Límanová Z; Srámková J
    Endokrinologie; 1981 Oct; 78(1):57-66. PubMed ID: 6797816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyrotropin-releasing hormone in critical illness: from a dopamine-dependent test to a strategy for increasing low serum triiodothyronine, prolactin, and growth hormone concentrations.
    Van den Berghe G; de Zegher F; Vlasselaers D; Schetz M; Verwaest C; Ferdinande P; Lauwers P
    Crit Care Med; 1996 Apr; 24(4):590-5. PubMed ID: 8612408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose effect of human growth hormone-releasing factor and thyrotropin-releasing factor on hormone concentrations in lactating dairy cows.
    Lapierre H; Petitclerc D; Pelletier G; Delorme L; Dubreuil P; Morisset J; Gaudreau P; Couture Y; Brazeau P
    Domest Anim Endocrinol; 1990 Oct; 7(4):485-95. PubMed ID: 2124532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.